Expert Opinion on Drug Delivery

Papers
(The TQCC of Expert Opinion on Drug Delivery is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen67
Artificial Intelligence’s role in colon-targeted drug delivery66
All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease58
Iontophoresis for the cutaneous delivery of nanoentraped drugs58
In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry56
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study55
How can nanoemulsions be used for photosensitizer drug delivery?54
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers f53
The quest to deliver high-dose rifampicin: can the inhaled approach help?52
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery52
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study52
Calcium phosphate coated nanoparticles for drug delivery: where are we now?47
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement46
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges46
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years43
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery40
Current insights into polymeric micelles for nasal drug delivery40
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications39
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs39
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition38
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study38
Acetalated dextran: a novel delivery platform for particle-based vaccines37
How can we optimize the delivery of IL-2 to traumatic brain injury patients?37
The challenges of drug delivery to the esophagus and how to overcome them37
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders37
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery36
Future applications of self-immolative polymers in drug delivery35
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review34
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms34
Current status and prospect for future advancements of long-acting antibody formulations32
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective31
Recent advances in the use of liquid crystalline nanoparticles for non-small cell lung cancer treatment31
Engineering polycaprolactone nanowires for pharmacologic efficacy31
Do the chitosan nanoparticles really augment the drugs’ transdermal fluxes: ending the debate using meta-analysis31
A randomized crossover study assessing critical errors, preferences, and ease of use of two multidose powder inhalers30
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?29
Calcium carbonate in drug delivery: functional carrier design, applications, and data-driven perspectives29
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice28
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances28
Novel formulations of metal-organic frameworks for controlled drug delivery28
Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs28
Potential bladder cancer therapeutic delivery systems: a recent update27
An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery27
Silica nanoparticles for brain cancer27
Progress and potential of nanobubbles for ultrasound-mediated drug delivery27
Current insights into drug-coated balloons for peripheral arterial disease26
Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?26
3D printed dosage forms, where are we headed?26
Can radiopharmaceuticals be delivered by quantum dots?25
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing25
An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems24
How might intraluminal drug-delivery strategies be improved to enhance arteriovenous fistula maturation and patency?24
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders24
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices24
The potential public health benefit of live-attenuated pertussis vaccines24
Solvent-exchange-based in situ forming implants: advances and challenges as long-lasting formulations24
Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery24
Emerging landscape of bioinformatics and artificial intelligence applications in cell-penetrating peptide-based delivery24
Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application23
Understanding the interaction forces between shield-triggered autoinjectors and skin: an in-depth noninvasive study23
Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo22
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles22
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving in-situ stability22
Platelets for advanced drug delivery in cancer22
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product22
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges22
Pediatric inhalation therapy and the aerodynamic rationale for age-based aerosol sizes21
Inhalation delivery of nucleic acid gene therapies in preclinical drug development21
Future applications of cyclic antimicrobial peptides in drug delivery21
Is electroporation the key to drug delivery in drug-resistant cancers?21
Polyphosphoester cubosomes: introducing a novel drug delivery system21
Treating glioblastoma with dextrin-based polymers21
Recent advances in antibacterial nanoformulations for endodontic applications21
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development21
Particle surface coating for dry powder inhaler formulations20
3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives20
Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity20
Microneedles for oral mucosal delivery – Current trends and perspective on future directions19
Development and approval of novel injectables: enhancing therapeutic innovations19
Polymer-based thermoresponsive hydrogels for controlled drug delivery19
An update on cell-penetrating peptides with intracellular organelle targeting19
Targeted transport of biotherapeutics at the blood-brain barrier19
Topical drug delivery to the retina: obstacles and routes to success18
Lipid-based nanosystems for wound healing18
Untethered shape-changing devices in the gastrointestinal tract18
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen18
Recent advances in drug delivery to the central nervous system by inhalation18
Biphasic drug release from electrospun structures17
Drug delivery and formulation development of hesperidin: a systematic review17
Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration17
Infusion-based drug delivery to the brain: what’s next?17
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids17
The impact of common pharmaceutical excipients on the gut microbiota17
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier17
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment17
An evolving perspective on novel modified release drug delivery systems for inhalational therapy16
An interview with professor Dermot O’Toole by Zoe Kenney, commissioning editor16
An update on the latest strategies in retinal drug delivery16
Correction16
Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer16
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities16
Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework16
Drug and stem cells delivery to salivary glands – a concise review16
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases16
Explicit analysis of in vivo , meterological and statistical hurdles in successful clinical translation of targeted nanomedicines and plausible remedial 16
Development of ROS-responsive liposomes toward targeted drug delivery15
Engineering trafficking pathways to overcome immunosuppressive barriers in solid tumor immunotherapy15
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery14
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods14
Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy14
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance14
Inhaled antifungal therapy: benefits, challenges, and clinical applications14
GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy14
The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices14
Advances in plasmonic-based MOF composites, their bio-applications, and perspectives in this field14
Nano-drug delivery system of natural products for disease prevention and treatment14
Recent developments in nanofiber-based fast-disintegrating drug delivery systems14
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier14
Advanced nano-delivery systems in H. pylori eradication: targeting, efficacy, and clinical translation14
A fluid and particle mechanics perspective of nasal drug delivery14
Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics13
Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy13
Future outcomes and current limitations of injectable implants for vocal fold scarring13
Solid lipid nanoparticles: a promising tool for insulin delivery13
Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines13
Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting13
Biopredictive tools for the development of injectable drug products13
Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations13
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis13
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence13
Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS13
1.3714270591736